Cargando…
Creation of human hematopoietic chimeric cell (HHCC) line as a novel strategy for tolerance induction in transplantation
BACKGROUND: Cell-based and chimerism-based therapies represent a promising approach for tolerance induction in transplantation. We propose a new cell therapy of the ex vivo created human hematopoietic chimeric cells (HHCC) as an alternative approach to bone marrow (BM)-based therapies in support of...
Autores principales: | Siemionow, Maria, Brodowska, Sonia, Różczka, Klaudia, Roesler, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813662/ https://www.ncbi.nlm.nih.gov/pubmed/36619595 http://dx.doi.org/10.21037/sci-2022-026 |
Ejemplares similares
-
Human Multi-Chimeric Cell (HMCC) Therapy as a Novel Approach for Tolerance Induction in Transplantation
por: Siemionow, Maria, et al.
Publicado: (2023) -
Novel Human Umbilical Di-Chimeric (HUDC) cell therapy for transplantation without life-long immunosuppression
por: Siemionow, Maria, et al.
Publicado: (2023) -
Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective
por: Yolcu, Esma S., et al.
Publicado: (2017) -
Chimerism-Based Experimental Models for Tolerance Induction in Vascularized Composite Allografts: Cleveland Clinic Research Experience
por: Siemionow, Maria, et al.
Publicado: (2013) -
Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Siemionow, Maria, et al.
Publicado: (2019)